Nicola Rowbotham
Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review
Rowbotham, Nicola; Smith, Sherie; Robinson, Karen; Smyth, Alan
Authors
Mrs SHERIE SMITH sherie.smith@nottingham.ac.uk
COCHRANE SYSTEMATIC REVIEWER
Karen Robinson
Alan Smyth
Abstract
Introduction:Cystic fibrosis (CF) is a multisystem disorder. Treatment is complex and evidence for treatment decisions may be absent. Characterising gaps in the research evidence will highlight treatment uncertainties and help prioritise research questions. We systematically identified the evidence gaps for treatment decisions in CF.
Methods: We searched for systematic reviews and guidelines on treatment interventions in CF. Two researchers identified eligible reviews with arbitration from a third. Using a structured framework, we extracted and characterised evidence gaps.
Results: There were 73 reviews and 21 guidelines that met our inclusion criteria. From these, we identified 148 evidence gaps across a range of treatment areas. We found 111 evidence gaps through systematic reviews and a further 37 from guidelines. The reason for an evidence gap could only be reliably characterised for systematic reviews. In most cases, there was more than one explanation—most commonly few or no trials (97/111 evidence gaps). Other important factors leading to evidence gaps were small sample size (49/111), inadequate duration of follow-up (38/111) or intervention (37/111) and factors relating to outcomes (35/111). Evidence gaps from both systematic reviews and guidelines fell into the following categories: Respiratory (91); Gastrointestinal (20); PhysiotherapyandExercise (16); Musculoskeletal (6); Endocrine (4); Basic defect of CF (8); Psychosocial (2); Ears, Nose and Throat (1).
Conclusions: We have compiled an up-to-date list of treatment uncertainties in CF and the reasons for these uncertainties. These can be used as a resource to aid researchers and funders when planning future trials.
PROSPERO registration number: Pre-results; CRD42015030111.
Citation
Rowbotham, N., Smith, S., Robinson, K., & Smyth, A. (2019). Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review. Thorax, 74(3), 229-236. https://doi.org/10.1136/thoraxjnl-2017-210858
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 28, 2018 |
Online Publication Date | Oct 9, 2018 |
Publication Date | 2019-03 |
Deposit Date | Sep 7, 2018 |
Publicly Available Date | Sep 7, 2018 |
Journal | Thorax |
Print ISSN | 0040-6376 |
Electronic ISSN | 1468-3296 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 74 |
Issue | 3 |
Pages | 229-236 |
DOI | https://doi.org/10.1136/thoraxjnl-2017-210858 |
Public URL | https://nottingham-repository.worktribe.com/output/1064268 |
Publisher URL | https://thorax.bmj.com/content/early/2018/10/09/thoraxjnl-2017-210858 |
Contract Date | Sep 7, 2018 |
Files
Evidence for treatment decisions in cystic fibrosis
(404 Kb)
PDF
You might also like
A refresh of the top 10 research priorities in cystic fibrosis
(2023)
Journal Article
Working in partnership with the patient community to develop outline trial designs in CF
(2021)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search